tirzepatide vs semaglutide for fat loss Tirzepatide vs Semaglutide: Which Weight

~10 Million Americans Used GLP-1 Medications in 2025 As of 2025, approximately 10 million individuals in the US used GLP-1 medications a number expected to significantly increase through 2026 and 2027 as pricing becomes more accessible and awareness continues to grow

Juan PF, Melanie JD, Julio R, Federico CPM, Laura FeL, Brandon KB, et al

By following the right timeline, adjusting your dose, and listening to your body, youll reduce side effects and maintain your overall progress

However, if you are also noticing strange smelling burps with repeated trips to the loo, it may be something unusual

Participants on the highest dose lost an average of 22.5% of their body weight over 72 weeks